Ultra-Fast radiation zaps skin cancer in new pilot trial
NCT ID NCT07608549
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study will test a new type of radiation called FLASH radiotherapy for people with cutaneous lymphoma, a rare skin cancer. Ten participants will receive a single, ultra-fast dose of radiation to their skin lesions. The main goal is to see if the treatment is safe and to measure how much radiation reaches the tumor.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- electron FLASH radiotherapy (ultra-high dose rate radiation delivered via Mobetron device)
- What this could lead to
- If successful, this could show that FLASH radiotherapy is a safe and effective way to treat skin lymphoma lesions with fewer side effects than standard radiation.
- What could go wrong
- This is a very early pilot study with only 10 participants, so results may not apply to everyone. The main goal is safety, not yet proving the treatment works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.